Scientists have used CRISPR genome editing to disable a gene mutation often seen in aggressive forms of melanoma that renders treatments as ineffective.
The findings of the study have been published in the CRISPR journal.
The scientists have used CRISPR genome editing to disable the mutation and restore treatment sensitivity to the cancer cells.
Medical Xpress has more.